Clinical Trial Update: HepB mAb19 in Individuals With Chronic Hepatitis B Infection [Phase 1]

View source ↗

Summary

This update indicates that a Phase 1 clinical trial of HepB mAb19 for chronic hepatitis B infection is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• HepB mAb19

Snippet

Sponsor: Rockefeller University | Conditions: Hepatitis b Virus, Hepatitis B | Phase 1 | Status: RECRUITING